Argonaut Therapeutics Alternatives & Competitors

12 companies similar to Argonaut Therapeutics — Argonaut Therapeutics uses PRMT5 inhibitors and companion diagnostics for precis...

Phoenix Molecular Designs

A clinical stage biopharmaceutical company designing precise cancer therapeutics to addres...

22 Series A $12.35M

San Diego, United States

Biotechnology Health Care +1

SOLID Therapeutics

An early-stage oncology company aiming to treat solid tumors

Denmark

Cascadian Therapeutics, Inc.

10 Post-IPO Equity $64.90M

Seattle, United States

Biotechnology Health Care +1

Quanta Therapeutics

35 Series D $140.70M

Biotechnology Health Care +2

Rival Readout

Competing with Argonaut Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

Breakpoint Therapeutics

Modulating DNA damage responses to cure cancer

3 Venture round $30.00M

Hamburg, Germany

Biotechnology Health Care +1

Rakuten Medical

Rakuten Medical, Inc. is a global biotechnology company in pursuit of conquering cancer.

120 Series E $737.59M

San Diego, United States

Biotechnology Health Care +1

Viewpoint Molecular Targeting, Inc.

Targeted α-Particle Radiotherapy for Cancer

10 Grant $27.26M

Coralville, United States

Biotechnology Health Care +2

ASC Oncology GmbH

RETHINK ONCOLOGY

Berlin, Germany

Biotechnology Health Care +1

Arcus Biosciences

Biopharmaceutical company developing differentiated molecules and combination therapies fo...

633 IPO $1.86B

Hayward, United States

Biopharma Biotechnology +3

ImCheck Therapeutics

Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic

57 Grant $193.11M

Marseille, France

Biopharma Biotechnology +3

Carrick Therapeutics

Transformative Cancer Medicines

16 Series C $155.00M

Dublin, Ireland

Biotechnology Health Care +2

About Argonaut Therapeutics

Argonaut Therapeutics is a health care startup founded in 2016, which has received a significant $2.57M corporate round investment from JW Pharmaceuticals on 29 October 2018. The company, a spin-out of Oxford University's Medical Sciences Division, is dedicated to leveraging PRMT5 inhibitors and companion diagnostics f...

Business keywords

Precision Therapeutics, Cancer Treatment, PRMT5 Inhibitors, Companion Diagnostics, Oxford University, Medical Research, Epigenetics, Precision Medicine, Cancer Therapy, Research Spin-out, Clinical Trials, Drug Development, Metastatic Tumors, Enzyme Targeting

Frequently Asked Questions

Companies similar to Argonaut Therapeutics include Phoenix Molecular Designs, SOLID Therapeutics, Cascadian Therapeutics, Inc., Quanta Therapeutics, ORIC Pharmaceuticals Inc.. They work in Health Care and Health and Wellness and share Argonaut Therapeutics's focus on precision medicine, drug development and clinical trials.

Bounce Watch lists 12 companies that share Argonaut Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Argonaut Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Argonaut Therapeutics Profile Phoenix Molecular Designs Alternatives SOLID Therapeutics Alternatives Cascadian Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Argonaut Therapeutics on 25 Jul 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.